Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy
APBI
A Phase II Study of Accelerated Partial Breast Radiotherapy With Either a Novel Breast Brachytherapy Technique - Mammosite or Intensity Modulated Radiotherapy
1 other identifier
interventional
291
1 country
6
Brief Summary
Accelerated Partial Breast Irradiation by Mammosite and intensity modulated radiotherapy is safe and effective in patients with early stage breast cancer resected by lumpectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 breast-cancer
Started Feb 2004
Longer than P75 for phase_2 breast-cancer
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2004
CompletedFirst Submitted
Initial submission to the registry
August 18, 2010
CompletedFirst Posted
Study publicly available on registry
August 19, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedJuly 11, 2013
July 1, 2013
10.5 years
August 18, 2010
July 10, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Overall Survival
2-15 years
Disease free survival
2-15 years
Cause specific survival
2-15 years
Ipsilateral breast failure
2-15 years
Secondary Outcomes (1)
Serious Adverse device-related Events
2-5 years
Study Arms (2)
Mammosite
EXPERIMENTALAccelerated Partial Breast Irradiation using Mammosite RTS
IMRT
EXPERIMENTALAccelerated partial breast irradiation using IMRT planning technique of external beam radiotherapy
Interventions
Treatment will be performed using high dose rate brachytherapy, starting between 2-5 days of implant, 34 Gy at 1 cm in 3.4 Gy fractions BID for 5 treatment days with typical boost dose od 10 Gy given in 2 fractions at least 6 hours apart.
Accelerated Partial Breast Irradiation using intensity modulated radiotherapy, a novel planning and delivery technique for external beam radiation
Eligibility Criteria
You may qualify if:
- Be a Tis, T1, N0, M0 AJC Classification
- Have negative surgical margins (\> or = 2 mm) after final surgery
- Should have adequate skin spacing between balloon surface and surface the skin (\> 7 mm)\*
- Patients with infiltrating lobular histologies should have breast MRI scanning as part of the initial staging to verify localized T1, or Tis disease
- Multifocal findings (define as 2 or more breast quadrants) on MRI scanning should be further evaluated by ultrasound and, if necessary biopsy, to exclude multiquadrant disease.
You may not qualify if:
- Be pregnant or breast-feeding
- Have collagen-vascular disease
- Inadequate surgical margins (\< 2 mm)
- Patients with malignant/suspicious calcifications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rocky Mountain Cancer Centerslead
- Charles Leonard, MDcollaborator
Study Sites (6)
Rocky Mountain Cancer Centers - Aurora
Aurora, Colorado, 80012, United States
Rocky Mountain Cancer Centers - Boulder
Boulder, Colorado, 80303, United States
Rocky Mountain Cancer Centers - Midtown
Denver, Colorado, 80128, United States
Rocky Mountain Cancer Centers - Littleton
Littleton, Colorado, 80120, United States
Rocky Mountain Cancer Centers - Sky Ridge
Lone Tree, Colorado, 80124, United States
Rocky Mountain Cancer Centers - Thornton
Thornton, Colorado, 80260, United States
Related Publications (7)
Leonard CE, Tallhamer M, Johnson T, Hunter K, Howell K, Kercher J, Widener J, Kaske T, Paul D, Sedlacek S, Carter DL. Clinical experience with image-guided radiotherapy in an accelerated partial breast intensity-modulated radiotherapy protocol. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):528-34. doi: 10.1016/j.ijrobp.2009.02.001. Epub 2009 May 19.
PMID: 19467799BACKGROUNDRusthoven KE, Carter DL, Howell K, Kercher JM, Henkenberns P, Hunter KL, Leonard CE. Accelerated partial-breast intensity-modulated radiotherapy results in improved dose distribution when compared with three-dimensional treatment-planning techniques. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):296-302. doi: 10.1016/j.ijrobp.2007.08.047.
PMID: 18086392BACKGROUNDLei RY, Leonard CE, Howell KT, Henkenberns PL, Johnson TK, Hobart TL, Fryman SP, Kercher JM, Widner JL, Kaske T, Carter DL. Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT). Breast Cancer Res Treat. 2013 Jul;140(1):119-33. doi: 10.1007/s10549-013-2623-x. Epub 2013 Jul 4.
PMID: 23824363RESULTLeonard CE, Johnson T, Tallhamer M, Howell K, Kercher J, Kaske T, Barke L, Sedlacek S, Hobart T, Carter DL. Accelerated partial breast intensity-modulated radiotherapy in women who have prior breast augmentation. Clin Breast Cancer. 2011 Jun;11(3):184-90. doi: 10.1016/j.clbc.2011.03.016. Epub 2011 May 4.
PMID: 21665139RESULTReeder R, Carter DL, Howell K, Henkenberns P, Tallhamer M, Johnson T, Kercher J, Widner J, Kaske T, Paul D, Sedlacek S, Leonard CE. Predictors for clinical outcomes after accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):92-7. doi: 10.1016/j.ijrobp.2008.06.1917. Epub 2008 Sep 9.
PMID: 18786783RESULTLeonard C, Carter D, Kercher J, Howell K, Henkenberns P, Tallhamer M, Cornish P, Hunter K, Kondrat J. Prospective trial of accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1291-8. doi: 10.1016/j.ijrobp.2006.11.016. Epub 2007 Jan 17.
PMID: 17234359RESULTLeonard CE, Wang Y, Asmar L, Lei RY, Howell KT, Henkenberns PL, Johnson TK, Hobart TL, Tole SP, Kercher JM, Widner JL, Barke L, Kaske T, Carter DL. A prospective Phase III trial evaluating patient self-reported pain and cosmesis in accelerated partial breast irradiation utilizing 3-D versus intensity-modulated radiotherapy. Cancer Med. 2021 Oct;10(20):7089-7100. doi: 10.1002/cam4.4242. Epub 2021 Sep 1.
PMID: 34469056DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dennis Carter, MD
Rocky Mountain Cancer Centers
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 18, 2010
First Posted
August 19, 2010
Study Start
February 1, 2004
Primary Completion
August 1, 2014
Study Completion
August 1, 2024
Last Updated
July 11, 2013
Record last verified: 2013-07